Coeptis Therapeutics Holdings, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Z Squared Inc. has filed a registration statement for the potential resale of 100,000 shares of common stock issuable upon the exercise of outstanding warrants.
NASDAQ
Z Squared Inc. has filed a registration statement for the resale of up to 41,584,562 shares of common stock by existing securityholders.
NASDAQ
Coeptis Therapeutics is filing an amendment to its S-1 registration statement to allow selling stockholders to resell up to 3,919,349 shares of common stock.
NASDAQ
Coeptis Therapeutics files an amended S-1 registration statement for the resale of up to 3,919,349 shares of common stock by selling stockholders, including shares issuable under a Standby Equity Purchase Agreement with YA II PN, LTD.
NASDAQ
Coeptis Therapeutics files an S-1 registration statement for the resale of up to 3,919,349 shares of common stock by selling stockholders, including shares issuable under a Standby Equity Purchase Agreement with Yorkville.